CANADA LIFE ASSURANCE Co
InsurancePosition in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1046192
WINNIPEG, A2
Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,222,480
-$310,691 QoQ
Shares Held
47,785
-2.5% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $112,895,525 across 19 Drug Manufacturers - Specialty & Generic names. SUPN ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
378,539 | $27,201,812 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
39,673 | $21,496,021 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
608,637 | $20,620,621 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
72,623 | $12,239,880 | |
| 5 | VTRS |
Viatris Inc
|
505,084 | $8,020,733 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
285,889 | $7,035,728 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
38,087 | $4,225,371 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
140,778 | $2,436,867 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,222,480 | 47,785 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,533,171 | 49,007 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,393,552 | 48,160 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,917,149 | 61,041 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,952,222 | 61,936 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,919,150 | 58,600 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,348,230 | 64,940 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,176,426 | 69,802 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,779,303 | 66,516 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,856,982 | 54,441 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,256,632 | 43,422 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,272,934 | 46,171 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,428,601 | 47,525 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,876,822 | 51,803 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,968,092 | 55,175 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,013,093 | 59,471 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,529,549 | 52,889 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,482,162 | 45,859 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,328,821 | 45,570 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,207,244 | 45,266 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,393,740 | 45,266 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,207,473 | 46,122 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,311,339 | 52,120 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,220,223 | 58,552 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $1,538,240 | 64,768 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,260,865 | 70,087 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||